Margaret Kloster

1.0k total citations
26 papers, 685 citations indexed

About

Margaret Kloster is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, Margaret Kloster has authored 26 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 6 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in Margaret Kloster's work include Cystic Fibrosis Research Advances (24 papers), Neonatal Respiratory Health Research (10 papers) and Tracheal and airway disorders (8 papers). Margaret Kloster is often cited by papers focused on Cystic Fibrosis Research Advances (24 papers), Neonatal Respiratory Health Research (10 papers) and Tracheal and airway disorders (8 papers). Margaret Kloster collaborates with scholars based in United States, Canada and United Kingdom. Margaret Kloster's co-authors include Nicole Mayer-Hamblett, Margaret Rosenfeld, Bonnie W. Ramsey, Valeria Thompson, Lisa Saiman, Gwendolyn S. Kerby, Stephanie D. Davis, Sonya L. Heltshe, Félix Ratjen and Larry C. Lands and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases and Biophysical Journal.

In The Last Decade

Margaret Kloster

26 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Margaret Kloster United States 15 604 125 80 79 49 26 685
Gary A. Mueller United States 5 427 0.7× 89 0.7× 53 0.7× 87 1.1× 25 0.5× 8 509
D. Nazareth United Kingdom 13 337 0.6× 63 0.5× 41 0.5× 47 0.6× 20 0.4× 56 500
Anita Laxova United States 5 660 1.1× 103 0.8× 109 1.4× 25 0.3× 78 1.6× 5 733
J. van der Laag Netherlands 12 311 0.5× 50 0.4× 61 0.8× 80 1.0× 55 1.1× 22 502
Gaudenz Hafen Switzerland 12 255 0.4× 62 0.5× 51 0.6× 49 0.6× 30 0.6× 32 395
Barbara Messore Italy 10 337 0.6× 60 0.5× 43 0.5× 27 0.3× 19 0.4× 18 401
Rosaria Casciaro Italy 12 280 0.5× 52 0.4× 53 0.7× 35 0.4× 12 0.2× 29 354
Simon C Langton Hewer United Kingdom 10 389 0.6× 101 0.8× 122 1.5× 34 0.4× 18 0.4× 23 531
Roxanne Strachan Australia 13 310 0.5× 153 1.2× 79 1.0× 25 0.3× 17 0.3× 17 433
Abaigeal Jackson Ireland 8 276 0.5× 38 0.3× 58 0.7× 24 0.3× 23 0.5× 16 361

Countries citing papers authored by Margaret Kloster

Since Specialization
Citations

This map shows the geographic impact of Margaret Kloster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret Kloster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret Kloster more than expected).

Fields of papers citing papers by Margaret Kloster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret Kloster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret Kloster. The network helps show where Margaret Kloster may publish in the future.

Co-authorship network of co-authors of Margaret Kloster

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret Kloster. A scholar is included among the top collaborators of Margaret Kloster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret Kloster. Margaret Kloster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gifford, Alex H., Katherine Odem‐Davis, Margaret Kloster, et al.. (2024). Self-reported chronic therapy use after 24-weeks of follow-up by participants who completed the simplify randomized, controlled trial. Journal of Cystic Fibrosis. 24(1). 91–97. 5 indexed citations
2.
Mayer-Hamblett, Nicole, Alex H. Gifford, Margaret Kloster, et al.. (2024). Impact of Discontinuing Both Hypertonic Saline and Dornase Alfa after Elexacaftor-Tezacaftor-Ivacaftor in Cystic Fibrosis. Annals of the American Thoracic Society. 21(11). 1507–1515. 7 indexed citations
3.
Gifford, Alex H., Margaret Kloster, Richard Russell, et al.. (2023). P090 Treatment use among SIMPLIFY trial participants through 24 weeks of follow-up. Journal of Cystic Fibrosis. 22. S91–S91. 1 indexed citations
4.
Magaret, Amalia, Jack C. Salerno, Jason F. Deen, et al.. (2020). Long-term azithromycin use is not associated with QT prolongation in children with cystic fibrosis. Journal of Cystic Fibrosis. 20(2). e16–e18. 5 indexed citations
5.
Goetz, Danielle, Benjamin T. Kopp, Ann Salvator, et al.. (2019). Pulmonary findings in infants with cystic fibrosis during the first year of life: Results from the Baby Observational and Nutrition Study (BONUS) cohort study. Pediatric Pulmonology. 54(5). 581–586. 10 indexed citations
6.
Mayer-Hamblett, Nicole, George Retsch‐Bogart, Margaret Kloster, et al.. (2018). Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial. American Journal of Respiratory and Critical Care Medicine. 198(9). 1177–1187. 73 indexed citations
7.
Leung, Daniel H., Sonya L. Heltshe, Drucy Borowitz, et al.. (2017). Effects of Diagnosis by Newborn Screening for Cystic Fibrosis on Weight and Length in the First Year of Life. JAMA Pediatrics. 171(6). 546–546. 77 indexed citations
8.
Gelfond, Daniel, Sonya L. Heltshe, M. Skalland, et al.. (2017). Pancreatic Enzyme Replacement Therapy Use in Infants With Cystic Fibrosis Diagnosed by Newborn Screening. Journal of Pediatric Gastroenterology and Nutrition. 66(4). 657–663. 21 indexed citations
9.
Thompson, Valeria, Nicole Mayer-Hamblett, Margaret Kloster, Diana Bilton, & Patrick A. Flume. (2015). Risk of hemoptysis in cystic fibrosis clinical trials: A retrospective cohort study. Journal of Cystic Fibrosis. 14(5). 632–638. 18 indexed citations
10.
Muhlebach, Marianne S., Sonya L. Heltshe, Elena B. Popowitch, et al.. (2015). Multicenter Observational Study on Factors and Outcomes Associated with Various Methicillin-Resistant Staphylococcus aureus Types in Children with Cystic Fibrosis. Annals of the American Thoracic Society. 12(6). 864–871. 21 indexed citations
11.
Heltshe, Sonya L., Lisa Saiman, Elena B. Popowitch, et al.. (2014). Outcomes and Treatment of Chronic Methicillin-ResistantStaphylococcus aureusDiffers by Staphylococcal Cassette Chromosomemec(SCCmec) Type in Children With Cystic Fibrosis. Journal of the Pediatric Infectious Diseases Society. 4(3). 225–231. 15 indexed citations
12.
Anstead, Michael, Lisa Saiman, Nicole Mayer-Hamblett, et al.. (2013). Pulmonary exacerbations in CF patients with early lung disease. Journal of Cystic Fibrosis. 13(1). 74–79. 25 indexed citations
13.
Rosenfeld, Margaret, Philip M. Farrell, Margaret Kloster, et al.. (2013). Association of lung function, chest radiographs and clinical features in infants with cystic fibrosis. European Respiratory Journal. 42(6). 1545–1552. 19 indexed citations
14.
Mayer-Hamblett, Nicole, Lisa Saiman, Larry C. Lands, et al.. (2013). Impact of acute antibiotic therapy on the pulmonary exacerbation endpoint in cystic fibrosis clinical trials. Contemporary Clinical Trials. 36(1). 99–105. 8 indexed citations
15.
Ratjen, Félix, Lisa Saiman, Nicole Mayer-Hamblett, et al.. (2012). Effect of Azithromycin on Systemic Markers of Inflammation in Patients With Cystic Fibrosis Uninfected With Pseudomonas aeruginosa. CHEST Journal. 142(5). 1259–1266. 96 indexed citations
16.
Brumback, Lyndia C., Stephanie D. Davis, Gwendolyn S. Kerby, et al.. (2012). Lung function from infancy to preschool in a cohort of children with cystic fibrosis. European Respiratory Journal. 41(1). 60–66. 18 indexed citations
17.
Mayer-Hamblett, Nicole, Margaret Kloster, Bonnie W. Ramsey, et al.. (2012). Incidence and clinical significance of elevated liver function tests in cystic fibrosis clinical trials. Contemporary Clinical Trials. 34(2). 232–238. 10 indexed citations
18.
Ren, Clement L., Margaret Rosenfeld, Oscar H. Mayer, et al.. (2011). Analysis of the associations between lung function and clinical features in preschool children with Cystic Fibrosis. Pediatric Pulmonology. 47(6). 574–581. 27 indexed citations
19.
Davis, Stephanie D., Margaret Rosenfeld, Gwendolyn S. Kerby, et al.. (2010). Multicenter Evaluation of Infant Lung Function Tests as Cystic Fibrosis Clinical Trial Endpoints. American Journal of Respiratory and Critical Care Medicine. 182(11). 1387–1397. 77 indexed citations
20.
Sen, Taner Z., Margaret Kloster, Robert L. Jernigan, et al.. (2008). Predicting the Complex Structure and Functional Motions of the Outer Membrane Transporter and Signal Transducer FecA. Biophysical Journal. 94(7). 2482–2491. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026